Lipid profile of patients with diabetes mellitus: a cross sectional study

G. D. Bhambhani, Rutu G. Bhambhani, Nilesh Chandradityasinh Thakor


Background: Dyslipidemia is one of the common disorders which is seen in most of the diabetes patients, which causes cardio vascular disorders. Objective: To detect the lipid abnormality in diabetic patients.

Methods: The study was carried out at Medicine Department, K.J. Mehta hospital, Amargadh, Bhavnagar during period from September 2014 to August 2015. The lipid profiles and the fasting blood sugar values of 100 type-1 diabetic patients, 100 type-2 diabetic patients and 50 healthy subjects were studied after taking informed consent. Their serum samples were assessed for fasting blood glucose (FBG), total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL) and high density lipoprotein cho­lesterol (HDL) by using standard biochemical methods. The data was collected by predesign, pretested proforma and analyzed using SPSS 17.0 (Trial version).

Results: Maximum Number of patients (37% and 44%) were from age group of 20-29 years in type-1 DM & 50-59 years in type-2 DM respectively. 53% cases of type-1 DM and 70 % cases of type-2 DM had less than 140 mg/dl level of Fasting Blood Sugar (FBS. 49 % patients of type-1 DM and 30% of type-2 showed more than 200 mg/dl level of Post Prandial Blood Sugar (PPBS). Majority of type 2 DM patients (72%) showed high serum cholesterol level, while only 12% of the type1 DM patients showed high serum cholesterol level. 95% of type 1 DM patients showed normal (10-190 mg/dl) serum triglyceride level, while only 26% of type 2 DM subjects showed normal level. Serum LDL level was high (>160 mg/dl) in 78% of type 2 DM patients, while only 19% of type 1 DM patients showed higher value. All patients of type 2 had normal serum HDL level.

Conclusions: The frequencies of the high cholesterol, high TG and high LDL levels were higher in the diabetic group, thus indicating that diabetic patients were more prone for dyslipidemia, which could cause cardiovascular disorders.



Lipid profile, Dyslipidemia, Diabetes, Serum cholesterol, Serum triglyceride, Serum LDL

Full Text:



Kishore J. National programme for control of diabetes, CVD and stroke. In: Kishore J, eds. National Health Programme of India. 9th ed. New Delhi: Century Publications; 2011: 480-489.

Roberto T, Dodesini AR, Lepore G. Lipid and renal disease. J Am Soc Nephrol. 2006;17:145-7.

Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diabetes Dev Ctries. 2010;30(1):22-6.

Chattanda SP, Mgonda YM. Diabetic dyslipidemia among diabetic patients attending specialized clinics in Dar es Salaam. Tanzania Med J. 2008;23(1):08-11.

Krishna P, Roopakala, Prasanna KM. Dyslipidemia in type 1 diabetes mellitus in the young. Int J Diabetes Dev Ctries. 2005;25(4):110-2.

Khan SR, Ayub N, Nawab S, Shamsi TS. Triglyceride profile in dyslipidemia of type 2 diabetes mellitus. J Coll Physicians Surg Pak. 2008;18(5):270-3.

Gadi R, Samaha FF. Dyslipidemia in type 2 diabetes mellitus. Curr Diabetes Rep. 2007;7(3):228-34.

Miller M. The epidemiology of triglycerides as a coronary artery disease risk factor. Clin Cardiol. 1999;22:111-6.

Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011.

Ahmad A, Khan AR, Raja ZA, Mustafa G. Measurement of serum cholesterol and triglyceride: evaluation in patients with diabetes, hypertension and cerebrovascular accidents in South Punjab. Professional. 2003;10(2):92-8.

Ahmed N, Khan J, Siddiqui TS. Frequency of dyslipidaemia in type 2 diabetes mellitus in patients of Hazara division. J Ayub Med Coll Abbottabad. 2008;20(2):51-4.

Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in non-insulin dependent diabetics compared to non-diabetic controls: a population based survey among Asians in Singapore. Atherosclerosis. 1998;136:25-31.

Sniderman AD, Scantlebury T, Cianfione K. Hypertriglyceridaemic hyperpob: the unappreciated atherogenic dyslipidaemia in type 2 diabetes mellitus. Ann Intern Med. 2001;135:447-59.

Gowri MS, Vander Westhuyzen DR, Bridges SR, Anderson JW. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler Thromb Vasc Biol. 1999;19:2226-33.

Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077-80.

Feinstein A. Clinical epidemiology. In: Feinstein A, eds. The Architecture of Clinical Research. 1st ed. New York, NY: WB Saunders Co.; 1985: 685-689.

Idogun ES, Unuigbe EI, Ogunro PS, Akinola OT, Famodu AA. Assessment of serum lipids in Nigerians with type 2 diabetes mellitus complications. Pak J Med Sci. 2007;23:708-12.

Albrki WM, Elzouki AN, El­Mansoury AM, Tashani OA. Lipid profiles in Libyan type II diabetics. J Sci Appls. 2007;1:18-23.

Khandekar S, Noeman SA, Muralidhar K, Gadallah M, Al­Sawaf KS. Central adiposity and atherogenic lipids in Saudi diabetics. Ann Saudi Med. 1994;14:329-32.